期刊
JOURNAL OF BREAST CANCER
卷 17, 期 3, 页码 200-206出版社
KOREAN BREAST CANCER SOC
DOI: 10.4048/jbc.2014.17.3.200
关键词
Breast neoplasms; Extracellular signal-regulated MAP kinases; Human SNCG protein; Proto-oncogene proteins c-akt; Small interfering RNA
类别
资金
- Basic Research Program for Scientific and Technological Innovation of Shenzhen City [JC201105170637, JCYJ20130329110955809, JCYJ20120613171430264]
- Key Program for Science and Technology of Shenzhen City [201101005]
- International Joint Program for Scientific and Technological Innovation of Shenzhen City [GJHZ20120614154716498, GJHZ20130412153906740]
Purpose: Synuclein-gamma (SNCG), which was initially identified as breast cancer specific gene 1, is highly expressed in advanced breast cancers, but not in normal or benign breast tissue. This study aimed to evaluate the effects of SNCG siRNA-treatment on breast cancer cells and elucidate the associated mechanisms. Methods: Vectors containing SNCG and negative control (NC) siRNAs were transfected into MDA-MB-231 cells; mRNA levels were determined by real-time polymerase chain reaction. Cell proliferation was evaluated using the MU assay, cell migration was assessed by the Transwell assay, apoptosis and cell cycle analyses Were conducted with the flow cytometer, and Western blot analysis was performed to determine the relative levels of AKT, ERK, p-AKT, and p-ERK expression. Results: SNCG mRNA levels were significantly reduced in MDA-MB-231 cells transfected with SNCG siRNA. Our results indicate that in SNCG siRNA-treated cells, cell migration and proliferation decreased significantly, apoptosis was induced, and the cell cycle was arrested. Western blot analysis indicated that the protein levels of p-AKT and p-ERK were much lower in the SNCG siRNA-treated groups, than in the control and NC groups. Conclusion: SNCG siRNA could decrease the migration and proliferation of breast cancer cells by downregulating the phosphorylation of AKT and ERK.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据